Loading...
Paw CBD, cbdMD's pet CBD brand, experienced a 64% increase in net sales, growing from approximately $750,000 in the March 2020 quarter to approximately $1,229,000 in the June 2020 quarter.
Paw CBD's sales increased by 64% from the March 2020 quarter to the June 2020 quarter.
Paw CBD is trending at over a $7 million annualized run rate.
cbdMD's direct-to-consumer (DTC) sales make up over 70% of the brand’s revenue.
The company is focusing on cross-selling, customer retention and education, and will be rolling out Paw CBD subscription and reward programs shortly.